VYN 20 (Vyndaqel tafamidis meglumine 20 mg)
Generic Name: tafamidis
Pill with imprint VYN 20 is Yellow, Capsule-shape and has been identified as Vyndaqel tafamidis meglumine 20 mg. It is supplied by Pfizer Inc.
Vyndaqel is used in the treatment of amyloid cardiomyopathy; amyloidogenic transthyretin amyloidosis and belongs to the drug class transthyretin stabilizers. Vyndaqel tafamidis meglumine 20 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for VYN 20
Vyndaqel
- Generic Name
- tafamidis
- Imprint
- VYN 20
- Strength
- tafamidis meglumine 20 mg
- Color
- Yellow
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Transthyretin stabilizers
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-1975
More about Vyndaqel (tafamidis)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Imprints, shape & color data
- Pricing & coupons
- En español
- Drug class: transthyretin stabilizers
- FDA approval history
Patient resources
Other brands
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.